Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 1662.HK
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q2 Δ in %
Current Ratio -9.16 2.13 2.34
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -71.47 6.47 22.67
Naive Interpretation member
2 Per Share
Metric Q4 Q2 Δ in %
Book Value 1.70 0.98 0.96
Cash 26.27 0.35 0.28
Capex 7.76 -0.02 -0.02
Free Cash Flow 669.40 0.09 -0.01
Revenue 111.49 0.77 0.37
Naive Interpretation member
3 Profitability
Metric Q4 Q2 Δ in %
Gross Margin 30.51 0.12 0.10
Operating Margin 185.92 0.03 < 0.005
ROA 329.85 < 0.005 < 0.005
ROE 319.76 0.02 < 0.005
ROIC 822.46 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 1662.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 1662.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 1662.HK is permitted for members.